Renal risks of sodium phosphate tablets for colonoscopy preparation: A review of adverse drug reactions reported to the US Food and Drug Administration

Colorectal Disease

Volumn 13, Issue 9, 2011, Pages

  Ehrenpreis, Eli D ^a   Parakkal, D ^a   Semer, R ^a   Du, H ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

Colonoscopy preparation; Lower body weight; Renal risk; Sodium phosphate tablet; Women

Indexed keywords

SODIUM DIHYDROGEN PHOSPHATE;

ARTICLE; BODY WEIGHT; COLONOSCOPY; FOOD AND DRUG ADMINISTRATION; GROUPS BY AGE; HUMAN; KIDNEY DISEASE; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; BODY WEIGHT; CATHARTICS; COLONOSCOPY; FEMALE; HUMANS; KIDNEY DISEASES; MALE; PHOSPHATES; RETROSPECTIVE STUDIES; SEX FACTORS; TABLETS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 80051726189     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02679.x     Document Type: Article

References (25)

1. Ehrenpreis ED, Nogueras JJ, Botoman VA et al. Serum electrolyte abnormalities secondary to Fleet's Phospho-Soda colonoscopy prep. Surg Endosc 1996; 10: 1022-4.
2. Beloosesky Y, Grinblat J, Weiss A et al. Electrolyte disorders following oral sodium phosphate administration for bowel cleansing in elderly patients. Arch Intern Med 2004; 163: 803-8.
3. Markowitz GS, Nasr SH, Klein P et al. Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleaning. Human Pathol 2004; 35: 675-84.
4. Markowitz GS, Stokes MB, Radhakrishnan J et al. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an under recognized cause of chronic renal failure. J Am Soc Nephrol 2005; 16: 3389-96.
5. Vanner SJ, MacDonald PH, Paterson WG et al. A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavages solution (Golightly) for bowel cleansing. Am J Gastroenterol 1990; 85: 422-7.
6. Hookey LC, Depew WT, Vanner S. The safety profile of oral sodium phosphate for colonic cleansing before colonoscopy in adults. Gastrointest Endosc 2002; 56: 895-902.
7. Cohen SM, Wexner SD, Binderow SR et al. Prospective, randomized, endoscopic-blinded trial comparing precolonoscopy bowel cleansing methods. Dis Colon Rectum 1994; 37: 689-96.
8. Kastenberg D, Chasen R, Choudhary C et al. Efficacy and safety of sodium phosphate tablets compared to PEG solution in colon cleansing: two identically designed, randomized, controlled, parallel group, multicenter phase II trials. Gastrointest Endosc 2001; 54: 705-13.
9. Ehrenpreis ED, Wieland JM, Cabral J et al. Symptomatic hypocalcemia, hypomagnesemia, and hyperphosphatemia secondary to Fleet's Phospho-Soda colonoscopy preparation in a patient with a jejunoileal bypass. Dig Dis Sci 1997; 42: 858-60.
10. Tan JJ, Tjandra JJ. Which is the optimal bowel preparation for colonoscopy - a meta-analysis. Colorectal Dis 2006; 8: 247-58.
11. Wexner SD, Beck DE, Baron TH et al. A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Dis Colon Rectum 2006; 49: 792-809.
12. Markowitz GS, Perazella MA. Acute phosphate nephropathy. Kidney Int 2009; 76: 1027-34.
13. Ehrenpreis ED, Varala K, Hannon B. Lower weight is a risk factor for calcium phosphate nephropathy with sodium phosphate colonoscopy preparation: a simulation study. Am J Gastroenterol 2008; 103: S408-55.
14. Ehrenpreis ED. Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis. Aliment Pharmacol Ther 2009; 29: 1202-11.
15. Khurana A, McLean L, Atkinson S et al. The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch Intern Med 2008; 168: 593-7.
16. Belsey J, Epstein O, Heresbach D. Systematic review: adverse event reports for oral sodium phosphate and polyethylene glycol. Aliment Pharmacol Ther 2008; 29: 15-28.
17. Mackey AC, Lanh Green L, Amand KS et al. Sodium phosphate tablets and acute phosphate nephropathy. Am J Gastroenterol 2009; 104: 1903-6.
18. DiPalma JA, Buckley SE, Warner BA et al. Biochemical effects of oral sodium phosphate. Dig Dis Sci 1996; 41: 749-53.
19. Patel V, Emmett M, Santa Ana CA et al. Pathogenesis of nephrocalcinosis after sodium phosphate catharsis to prepare for colonoscopy: intestinal phosphate absorption and its effect on urine mineral and electrolyte excretion. Hum Pathol 2007; 28: 193-4.
20. Lien YHH. Is bowel preparation before colonoscopy a risky business for the kidney? Nat Clin Pract Nephrol 2008; 4: 606-14.
21. Asplin JR, Mandel NS, Coe FL. Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol 1996; 270: F604-13.
22. Casais MN, Rosa-Diez G, Pérez S et al. Hyperphosphatemia after sodium phosphate laxatives in low risk patients: prospective study. World J Gastroenterol 2009; 15: 5960-5.
23. Parakkal D, Ehrenpreis ED. Calcium phosphate nephropathy from colonoscopy preparations: effect of body weight. Am J Gastroenterol 2010; 105: 705.
24. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
25. Statistical abstracts on Health and Welfare in Japan 2008. Health and Welfare statistics association, Japan. (accessed 20 May 2010).